Could OTUD6B enable more targeted treatment options for TNBC?

Researchers have discovered that targeting a protein called OTUD6B may prevent aggressive breast cancer cells from growing, dividing and forming tumors. In this interview, we speak with Judy Coulson (University of Liverpool, UK) to explore the potential of OTUD6B in paving the way for more effective treatments for TNBC. Coulson also shares insights into her efforts to develop more ethical animal models within cancer research. Could you provide a breakdown of your research on the role of OTUD6B in TNBC? OTUD6B is a member of a family of around 100 deubiquitylase enzymes, known as DUBs, that remove ubiquitin tags from...